IFNA2 and acquired polycythemia vera: To evaluate the impact of acquired chromosomal aberrations we analyzed chromosomal lesions by high-resolution SNP microarrays in PV patients treated with a new formulation of peg-IFNα (AOP2014/P1101, peg-proline-IFNα-2b) in a phase I/II clinical trial.